• Patients receive oral imatinib mesylate twice daily on days 1-28. (knowcancer.com)
  • Preclinical data shows improvements in response for the combination of imatinib mesylate (IM, Gleevec) and gemcitabine (GEM) therapy compared with GEM alone. (aacrjournals.org)
  • Imatinib mesylate and AMN107 are tyrosine kinase inhibitors that inhibit fibroblast proliferation and collagen production in lungs and skin. (eur.nl)
  • This study was conducted to determine whether imatinib mesylate and AMN107 inhibit orbital fibroblast proliferation and hyaluronan production induced by PDGF-BB and TGF-β1and whether expression of the genes PDGF-B and TGF-B1(growth factors suggested to play a role in GO) are increased in GO orbital tissues. (eur.nl)
  • Orbital fibroblasts were cultured from eight patients with GO and three control patients and the effect of imatinib mesylate and AMN107 on PDGF-BB and TGF-β1-induced orbital fibroblast proliferation, signaling cascades, hyaluronan synthase (HAS) gene expression and hyaluronan production were determined. (eur.nl)
  • Imatinib mesylate and AMN107 inhibited PDGF-BB-induced orbital fibroblast proliferation, HAS induction and hyaluronan production by blocking PDGFreceptor phosphorylation. (eur.nl)
  • This induction was not inhibited by imatinib mesylate or AMN107, due to the inability of TGF-β1to activate c-Abl kinase activity in orbital fibroblasts. (eur.nl)
  • Nevertheless, imatinib mesylate and AMN107 should be considered as treatment candidates for GO. (eur.nl)
  • Imatinib mesylate (GLEEVEC, GLIVEC, formerly STI571) has demonstrated unprecedented efficacy as first-line therapy for treatment for all phases of chronic myelogenous leukemia and metastatic and unresectable malignant gastrointestinal stromal tumors. (aspetjournals.org)
  • Disposition and biotransformation of imatinib were studied in four male healthy volunteers after a single oral dose of 239 mg of 14 C-labeled imatinib mesylate. (aspetjournals.org)
  • Imatinib mesylate (IM) is a small molecule inhibitor of protein tyrosine kinases. (prinsesmaximacentrum.nl)
  • Imatinib mesylate, a small-molecule inhibitor of the KIT tyrosine kinase, provides a rapid but not durable clinical response in KIT-mutant melanoma. (elsevierpure.com)
  • Herein, we designed clinical trial of co-administrating imatinib mesylate and pembrolizumab (anti-PD-1 antibody) to evaluate its safety and efficacy.Methods and analysis:This is an open-label, single-arm, phase I/II clinical trial involving Japanese patients with metastatic KIT-mutant melanoma that are refractory to standard therapy including anti-PD-1 therapy. (elsevierpure.com)
  • Phase I study is a dose-escalation study comprising two dose levels of imatinib mesylate (200 and 400 mg/day, respectively) with fixed dose of pembrolizumab (200 mg every 3 weeks) to evaluate safety and tolerability and determine recommended phase II dose. (elsevierpure.com)
  • The primary endpoint of the phase II study is the objective response rate after 4 cycles (3 weeks/cycle) of pembrolizumab and imatinib mesylate at the dose determined in phase I, based on RECIST version 1.1. (elsevierpure.com)
  • Imatinib mesylate is currently the drug of choice to treat chronic myeloid leukemia. (altmetric.com)
  • It is used in patients whose condition has become worse while taking imatinib mesylate or who are not able to take it. (cancer.gov)
  • Imatinib mesylate for unmutated hypereosinophilic syndromes: Does it work? (efim.org)
  • The high efficacy of tyrosine kinase inhibitor, imatinib mesylate (IM), is well-documented in patients with hypereosinophilic syndromes (HES) and detectable rearrangements of platelet-derived growth factor receptor α or β (PDGFRA/B) [1]. (efim.org)
  • According to IQVIA, US sales of Imatinib Mesylate Tablets were approximately $831 million in the 12 months ending August 2018. (hikma.com)
  • Imatinib mesylate is often associated with edema and occasionally serious fluid retention. (hikma.com)
  • 65 years) or those taking higher doses of imatinib mesylate. (hikma.com)
  • Severe superficial edema was reported in 1.5% of newly diagnosed CML patients taking imatinib mesylate, and in 2%-6% of other adult CML patients taking imatinib mesylate. (hikma.com)
  • In addition, other severe fluid retention (e.g., pleural effusion, pericardial effusion, pulmonary edema, and ascites) reactions were reported in 1.3% of newly diagnosed CML patients taking imatinib mesylate, and in 2%-6% of other adult CML patients taking imatinib mesylate. (hikma.com)
  • In a randomized trial in patients with newly diagnosed Ph+ CML in chronic phase comparing imatinib mesylate and nilotinib, severe (Grade 3 or 4) fluid retention occurred in 2.5% of patients receiving imatinib mesylate and in 3.9% of patients receiving nilotinib 300 mg twice daily. (hikma.com)
  • Effusions (including pleural effusion, pericardial effusion, ascites) or pulmonary edema were observed in 2.1% (none were Grade 3 or 4) of patients in the imatinib mesylate arm and 2.2% (0.7% Grade 3 or 4) of patients in the nilotinib 300 mg twice daily arm. (hikma.com)
  • Requests for investigator-initiated trials have been granted for COVID-19-related clinical studies of ruxolitinib, canakinumab, imatinib mesylate, secukinumab, hydroxychloroquine and valsartan. (novartis.com)
  • Imatinib mesylate (IM), a potent inhibitor of the BCR/ABL tyrosine kinase, has become standard first-line therapy for patients with chronic myeloid leukemia (CML), but the frequency of resistance increases in advancing stages of disease. (lu.se)
  • Treatment of patients with gastrointestinal stromal tumour with imatinib mesylate]. (bvsalud.org)
  • They also looked at three drugs for chronic myeloid leukemia: dasatinib (Sprycel), imatinib mesylate (Gleevec), and nilotinib hydrochloride monohydrate (Tasigna). (medscape.com)
  • Pradaxa (dabigatran etexilate mesylate), a new oral anticoagulant, achieved Food & Drug Administration ("FDA") approval on October 19, 2010. (searcylaw.com)
  • Boehringer Ingelheim announced results from an interim analysis of the Phase 3 RE-VERSE AS patient study with idarucizumab for urgent reversal of the anticoagulant effect of Pradaxa (dabigatran etexilate mesylate). (empr.com)
  • The Food and Drug Administration (FDA) has granted Priority Review to the Biologics License Application (BLA) for idarucizumab (Boehringer Ingelheim) to reverse the anticoagulant effect of Pradaxa (dabigatran etexilate mesylate) in patients needing emergency intervention or experiencing an uncontrolled or life-threatening bleeding event. (empr.com)
  • Boehringer Ingelheim announced that the FDA has accepted for filing the supplemental New Drug Application (sNDA) for Pradaxa (dabigatran etexilate mesylate) for the prophylaxis of deep venous thrombosis (DVT) and pulmonary embolism (PE) in patients who have had primary elective total hip replacement surgery. (empr.com)
  • Boehringer Ingelheim announced that it has submitted a Biologics License Application (BLA) to the FDA, requesting accelerated approval for the use of idarucizumab to reverse the anticoagulant effect of Pradaxa (dabigatran etexilate mesylate). (empr.com)
  • The FDA has granted Breakthrough Therapy designation to idarucizumab (Boehringer Ingelheim), an investigational fully humanized antibody fragment (Fab), being evaluated as a specific antidote for Pradaxa (dabigatran etexilate mesylate). (empr.com)
  • To determine the frequency and severity of adverse effects of Gleevec in this cohort of patients as assessed by CTC. (knowcancer.com)
  • Corlopam (fenoldopam mesylate) Injection is a dopamine receptor agonist (vasodilator) used for in-hospital, short-term (up to 48 hours) management of severe high blood pressure ( hypertension ) when rapid, but quickly reversible, emergency reduction of blood pressure is indicated. (rxlist.com)
  • Our Corlopam (fenoldopam mesylate) Injection Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication. (rxlist.com)
  • Corlopam (fenoldopam mesylate) injection, USP is a dopamine D1-like receptor agonist . (rxlist.com)
  • These highlights do not include all the information needed to use DEFEROXAMINE MESYLATE safely and effectively. (nih.gov)
  • See full prescribing information for DEFEROXAMINE MESYLATE. (nih.gov)
  • Deferoxamine mesylate is not indicated for the treatment of primary hemochromatosis (since phlebotomy is the method of choice for removing excess iron in this disorder). (nih.gov)
  • See Full Prescribing Information for instructions on preparation of Deferoxamine mesylate for administration. (nih.gov)
  • For injection: 500 mg of deferoxamine mesylate as a lyophilized powder in single-dose fliptop vial for reconstitution. (nih.gov)
  • Discontinue Deferoxamine mesylate and initiate appropriate treatment immediately. (nih.gov)
  • Delay Vitamin C for one month after start of Deferoxamine mesylate. (nih.gov)
  • However, compliance and acceptability of deferoxamine therapy in patients with nonhemochromatosis iron overload is poor. (medscape.com)
  • After thorough explanation of the treat- and short half-life which can form a trans- ment and the study, written consent was portable deferoxamine-iron complex or obtained from patients or their parents. (who.int)
  • IV deferoxamine, 130 mg/kg per day over 10-14 hours (maximum 5 g) was ad- ministered daily for 5 days to all patients. (who.int)
  • SD 14.2) months, starting deferoxamine at 5 (SD 0.48) years and taking cardiotonic drugs for at least 1 month (all patients were on digoxin, 93.3% on captopril and 80.0% first evaluation (after 2 days of deferoxam- on furosemide). (who.int)
  • Doxazosin mesylate is a quinazoline compound that is a selective inhibitor of the alpha 1 subtype of alpha adrenergic receptors. (nih.gov)
  • RESCRIPTOR tablets contain delavirdine mesylate, a synthetic non-nucleoside reverse transcriptase inhibitor (NNRTI) of the human immunodeficiency virus type 1 (HIV-1). (drugs.com)
  • Methods: We evaluated the IRF4 expression kinetics during tyrosine kinase inhibitor (TKI) treatment in a cohort of 116 chronic myeloid leukemia (CML) patients to elucidate its role in the disease course. (karger.com)
  • Because alternatives to the use of rifampin for antituberculosis treatment are now available, the previously recommended practice of stopping protease inhibitor therapy to allow the use of rifampin for TB treatment is no longer recommended for patients with HIV-related TB. (cdc.gov)
  • What is the mode of buying Parlodel (Bromocriptine Mesylate) online? (medsengage.com)
  • It is now easy to buy Parlodel (Bromocriptine Mesylate) by placing an order at MedsEngage Pharmacy. (medsengage.com)
  • How can patients get Parlodel (Bromocriptine Mesylate) Online? (medsengage.com)
  • Yes, licensed doctors advise Parlodel (Bromocriptine Mesylate) online after a medical evaluation. (medsengage.com)
  • Physicians give a prescription to their patients and after patients can share the prescription for Parlodel (Bromocriptine Mesylate) with us via email, fax or upload over the website. (medsengage.com)
  • Is a prescription required for Parlodel (Bromocriptine Mesylate)? (medsengage.com)
  • As we are a Certified Canadian pharmacy online so we required a prescription for Parlodel (Bromocriptine Mesylate) that can only be bought with a prescription provided by doctor. (medsengage.com)
  • While processing the order for Parlodel (Bromocriptine Mesylate), it is better to get a valid prescription from the concerned healthcare provider. (medsengage.com)
  • What is the maximum quantity of Parlodel (Bromocriptine Mesylate) that can be ordered? (medsengage.com)
  • 90-days supply is the maximum amount of Parlodel (Bromocriptine Mesylate) that can be ordered online from MedsEngage at a time. (medsengage.com)
  • How about the safety of ordering Parlodel (Bromocriptine Mesylate) online from MedsEngage? (medsengage.com)
  • As a certified Canadian Pharmacy , MedsEngage is a totally safe and secure online way to order Parlodel (Bromocriptine Mesylate). (medsengage.com)
  • You just only need to have your prescription of Parlodel (Bromocriptine Mesylate) from a licensed doctor. (medsengage.com)
  • What about coupons for Parlodel (Bromocriptine Mesylate)? (medsengage.com)
  • Yes, coupons for Parlodel (Bromocriptine Mesylate) are available at MedsEngage Pharmacy. (medsengage.com)
  • They can use the Parlodel (Bromocriptine Mesylate) coupon at checkout to attain swift discounts so that they can pay less for their prescription. (medsengage.com)
  • An express shipping option is present with MedsEngage Pharmacy for Parlodel (Bromocriptine Mesylate). (medsengage.com)
  • People can check this option at the checkout page while processing their order of Parlodel (Bromocriptine Mesylate). (medsengage.com)
  • It is easy and time-saving to get a refill of Parlodel (Bromocriptine Mesylate) with MedsEngage. (medsengage.com)
  • We are donating hydroxychloroquine tablets for COVID-19 patients including for use in this and other clinical trials with the hope that researchers and healthcare workers can quickly and scientifically determine whether hydroxychloroquine can help patients around the world combat this disease," said Richard Saynor, CEO of Sandoz. (novartis.com)
  • The goals of this study were to determine the maximum tolerated dose (MTD) of IL-2 combined with IM at a constant dose of 400 mg, the pharmacokinetics of IM and IL-2, as well as toxicity and clinical efficacy of this immunotherapeutic regimen in patients affected by advanced tumors. (prinsesmaximacentrum.nl)
  • Auditory and Ocular Toxicity: Have been reported when administered over prolonged periods of time, at high doses, or in patients with low ferritin levels. (nih.gov)
  • Antidotes for iron toxicity are used in patients with hemochromatosis that is associated with significant anemia or severe end-organ involvement. (medscape.com)
  • The dose of this medicine will be different for different patients. (mayoclinic.org)
  • The drug dose rate of Corlopam is individualized for each patient according to body weight and according to the desired rapidity and extent of pharmacodynamic effect. (rxlist.com)
  • Uroflowmetric evaluations were performed at times of peak (2 to 6 hours post-dose) and/or trough (24 hours post-dose) plasma concentrations of doxazosin mesylate. (nih.gov)
  • 36 patients received a dose of 8 mg doxazosin mesylate. (nih.gov)
  • Purpose: This dose-ranging trial of intravenous dolasetron mesylate (MDL73, 147EF) was performed to determine its adverse and antiemetic effects in patients receiving cisplatin at doses ≥ 100 mg/m 2 . (elsevierpure.com)
  • Patients and Methods: Eighty-nine patients treated with initial cisplatin received a single intravenous dose of dolasetron mesylate administered over 20 minutes beginning 30 minutes before chemotherapy. (elsevierpure.com)
  • This is a multicenter, open-label, Phase 1/2a dose escalation and expansion study of orally administered emavusertib (CA-4948) monotherapy in adult patients with Acute Myelogenous Leukemia (AML) or high risk Myelodysplastic Syndrome (MDS). (rochester.edu)
  • In pediatric patients and adults, maximum dose should not exceed 40 mg/kg/day and 60 mg/kg/day, respectively. (nih.gov)
  • D.H.E. 45® (dihydroergotamine mesylate) Injection, USP should be administered in a dose of 1 mL intravenously, intramuscularly or subcutaneously. (rxlist.com)
  • In a clinical study of 12 patients with open-angle glaucoma or ocular hypertension (mean baseline intraocular pressure was 29.2 mm Hg with a range of 22 to 33 mm Hg), infusion of fenoldopam at escalating doses ranging from 0.05 to 0.5 mcg/kg/min over a 3.5 hour period caused a dose-dependent increase in intraocular pressure (IOP). (pfizermedicalinformation.com)
  • The conventional dose of remifentanil combined with dexmedetomidine anesthesia has a good anesthetic effect in clinical applications, but at the same time, drug-related side effects are strong, and even excessive sedation of patients occurs, which is not conducive to patient safety [ 4 ]. (hindawi.com)
  • Patients should not alter the dose or discontinue therapy without consulting with their doctor. (pharmacycode.com)
  • If a dose is missed, patients should take the dose as soon as possible and then return to their normal schedule. (pharmacycode.com)
  • However, if a dose is skipped, the patient should not double the next dose. (pharmacycode.com)
  • With the development of tumor molecular heterogeneity theory(12), there are still some patients with GIST who are sensitive to radiotherapy, especially for the patients with advanced stage(13-16).In addition, with the development of imaging technology and modern tissue and organ radiation technology, it has become a reality to concentrate high-dose radiation locally in abdominal cavity tumors(12), which challenges RT's insensitivity to GISTs. (researchsquare.com)
  • Haemosiderosis, which plays a considerable function in thalassaemia patients before and role in early mortality, can be prevented or after treatment with high-dose deferoxam- postponed by iron-chelating agents which ine. (who.int)
  • The efficacy of doxazosin mesylate was evaluated extensively in over 900 patients with BPH in double-blind, placebo-controlled trials. (nih.gov)
  • Several clinical studies have demonstrated the efficacy of chloroquine phosphate and nafamostat mesylate with COVID-19. (elsevierpure.com)
  • Totally, a target size of 22 patients will be expected.Discussion:If this study shows efficacy and acceptable safety profile, it will contribute to the development of novel treatment option for patients with KIT-mutant melanoma that are refractory to standard therapy.Trial registration:NCT04546074. (elsevierpure.com)
  • Intravenous Administration: Only for patients in a state of cardiovascular collapse. (nih.gov)
  • Intravenous Administration: 20 mg/kg/day to 40 mg/kg/day for pediatric patients and 40 mg/kg/day to 50 mg/kg/day over 8 hours to 12 hours in adults for 5 days to 7 days per week. (nih.gov)
  • As adjuvant therapy in patients who have had a nephrectomy (surgery to remove the kidney) and have a high risk that the cancer will come back. (cancer.gov)
  • Idhifa is indicated for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) with an isocitrate dehydrogenase-2 (IDH2) mutation. (pharmaceutical-technology.com)
  • Selumetinib in paediatric patients with BRAF -aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicenter, phase 2 trial. (medscape.org)
  • Adult patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). (hikma.com)
  • SEE NAMCS PATIENT DATASET NAMES FOR DSN ABSTRACT General Information This material provides documentation for users of the Micro-Data tapes of the National Ambulatory Medical Care Survey (NAMCS) conducted by the National Center for Health Statistics. (cdc.gov)
  • DSN: CC37.NAMCS90.PATIENTS ABSTRACT This material provides documentation for users of the Micro-Data tapes of the National Ambulatory Medical Care Survey (NAMCS) conducted by the National Center for Health Statistics. (cdc.gov)
  • Growth Suppression: Has occurred in pediatric patients treated with high doses and concomitant low ferritin levels. (nih.gov)
  • 0.8 mcg/kg/min in pediatric patients. (pfizermedicalinformation.com)
  • In pediatric patients for short-term reduction in blood pressure ( 1.2 ). (pfizermedicalinformation.com)
  • Trametinib in pediatric patients with neurofibromatosis type 1-associated plexiform neurofibroma: a phase I/II study. (medscape.org)
  • Newly diagnosed adult and pediatric patients with Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase. (hikma.com)
  • D.H.E. 45 (dihydroergotamine mesylate) is an ergot alkaloid used to treat a migraine or cluster headache attack. (rxlist.com)
  • Our D.H.E. 45 (dihydroergotamine mesylate) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication. (rxlist.com)
  • D.H.E. 45 (dihydroergotamine) ® is ergotamine hydrogenated in the 9, 10 position as the mesylate salt. (rxlist.com)
  • D.H.E. 45® (dihydroergotamine mesylate) Injection, USP is indicated for the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes. (rxlist.com)
  • Available as a clear, colorless, sterile solution in single 1 mL sterile ampuls containing 1 mg of dihydroergotamine mesylate per mL, in packages of 10 (NDC 0078-0041-01). (rxlist.com)
  • Serious cardiac events, including some that have been fatal, have occurred following use of D.H.E. 45® (dihydroergotamine mesylate) Injection, USP, but are extremely rare. (rxlist.com)
  • In the human prostate, doxazosin mesylate antagonizes phenylephrine (alpha 1 agonist)-induced contractions, in vitro , and binds with high affinity to the alpha 1c adrenoceptor. (nih.gov)
  • The number of people infected with severe acute respiratory syndrome coronavirus 2 is increasing globally, and some patients have a fatal clinical course. (elsevierpure.com)
  • Here, we report the case of a Japanese patient with COVID-19 with severe respiratory failure who improved following the administration of hydroxychloroquine and continuous hemodiafiltlation with nafamostat mesylate. (elsevierpure.com)
  • Hence, hydroxychloroquine with nafamostat mesylate might be a treatment option for severe COVID-19. (elsevierpure.com)
  • Patients with severe renal disease or anuria. (nih.gov)
  • In adult patients for short term management of severe hypertension when rapid and reversible reduction of blood pressure is clinically indicated, including for malignant hypertension with deteriorating end-organ function ( 1.1 ). (pfizermedicalinformation.com)
  • Pradaxa (also known as Dabigatran Etexilate) is an inactive "parent" drug that relies on the body's metabolism to eventually manufacture a form of the drug that the body can use as an anti-coagulant, a process that occurs after the drug has been ingested by a patient. (searcylaw.com)
  • Pradaxa is a blood thinner and is supposed to be prescribed to patients who suffer from the cardiac disorder atrial fibrillation. (searcylaw.com)
  • One notable advantage of using Pradaxa to replace Warfarin to prevent clot formation is the elimination of INR testing in patients taking Pradaxa. (searcylaw.com)
  • Boehringer Ingelheim presented positive results of its Phase 3 RE-VERSE AD study for idarucizumab as a reversal agent for the anticoagulant effect of Pradaxa (dabigatran) in patients needing emergency surgery or for life-threatening or uncontrolled bleeding events. (empr.com)
  • In all three studies, doxazosin mesylate resulted in statistically significant relief of obstructive and irritative symptoms compared to placebo. (nih.gov)
  • Another study showed that adding Januvia decreased HbA1c by a mean difference of 0.9 percent compared to placebo in patients failing treatment with the combination of metformin and the sulfonylurea glimepiride, and 0.6 percent compared to placebo in patients failing treatment with glimepiride alone. (bioworld.com)
  • Conclusion: Dolasetron mesylate can be administered safely at doses up to 5.0 mg/kg, with comparable complete protection rates and increased adverse effects at doses greater than 2.4 mg/kg. (elsevierpure.com)
  • Transport to the nucleus may involve specific protein-to-protein interactions that occur in certain cell types only, possibly explaining the selective neuronal vulnerability present in patients with HD. (medscape.com)
  • Each doxazosin mesylate tablet, for oral administration, contains 1 mg, 2 mg, 4 mg, or 8 mg of doxazosin as the free base. (nih.gov)
  • Each RESCRIPTOR tablet, for oral administration, contains 200 mg of delavirdine mesylate (henceforth referred to as delavirdine). (drugs.com)
  • Doxazosin mesylate is freely soluble in dimethylsulfoxide, soluble in dimethylformamide, slightly soluble in methanol, ethanol, and water (0.8% at 25°C), and very slightly soluble in acetone and methylene chloride. (nih.gov)
  • This regimen re- important causes of mortality and morbid- sulted in increased LVEF in 50% of the pa- ity in patients with thalassaemia major [1]. (who.int)
  • Ideally, the management of TB among HIV-infected patients taking antiretroviral drugs requires a) directly observed therapy, b) availability of experienced and coordinated TB/HIV care givers, and in most situations, c) use of a TB treatment regimen that includes rifabutin instead of rifampin. (cdc.gov)
  • Following administration of delavirdine 400 mg 3 times daily (n = 67, HIV-1-infected patients), the mean ±SD steady-state peak plasma concentration (C max ) was 35 ± 20 microM (range: 2 to 100 microM), systemic exposure (AUC) was 180 ± 100 microM per hour (range: 5 to 515 microM per hour), and trough concentration (C min ) was 15 ± 10 microM (range: 0.1 to 45 microM). (drugs.com)
  • Intramuscular Administration: Use for all patients not in shock. (nih.gov)
  • Basel, April 20, 2020 - Novartis has reached an agreement with the US Food and Drug Administration (FDA) to proceed with a Phase III clinical trial with approximately 440 patients to evaluate the use of hydroxychloroquine for the treatment of hospitalized patients with COVID-19 disease. (novartis.com)
  • All HIV-infected patients undergoing treatment for TB should be evaluated for antiretroviral therapy, because most patients with HIV-related TB are candidates for concurrent administration of antituberculosis and antiretroviral drug therapies. (cdc.gov)
  • Gastric gastrointestinal stromal tumor (GIST) en face. (medscape.com)
  • Cytotec is used for reducing the risk of stomach ulcers in certain patients who take nonsteroidal anti-inflammatory drugs (NSAIDs). (terminally-incoherent.com)
  • In the wake of safety concerns about GlaxoSmithKline plc's diabetes drug Avandia (rosiglitazone maleate), Merck also presented a meta-analysis of nine late-stage trials in more than 5,000 patients demonstrating that Januvia was well tolerated, with an overall incidence of adverse events similar to comparator drugs and placebo. (bioworld.com)
  • VIRACEPT may interact with some drugs, therefore, patients should be advised to report to their doctor the use of any other prescription or non-prescription medication. (pharmacycode.com)
  • A study of the drugs selumetinib verus carboplatin/vincristine in patients with neurofibromatosis and low-grade glioma. (medscape.org)
  • Because oncology is a high-risk disease area and the drugs are very expensive, decisions about prescribing should ideally be determined by a doctor-patient discussion that is free from outside influences," Dusetzina said by email. (medscape.com)
  • Each drug has a unique risks and benefit profile, even when considering two drugs from the same class, and often costs to the patient and society vary as well," Jagsi, who wasn't involved in the study, said by email. (medscape.com)
  • Adult patients with unresectable, recurrent, and/or metastatic dermatofibrosarcoma protuberans (DFSP). (hikma.com)
  • Delavirdine mesylate is an odorless white-to-tan crystalline powder. (drugs.com)
  • In patients with serum ferritin level below 2,000 ng/mL require about 25 mg/kg/day. (nih.gov)
  • Patients with higher serum ferritin may require up to 55 mg/kg/day. (nih.gov)
  • Doxazosin mesylate treatment was superior to placebo in improving patient symptoms and urinary flow rate. (nih.gov)
  • In three placebo-controlled studies of 14 to 16 weeks duration obstructive symptoms (hesitation, intermittency, dribbling, weak urinary stream, incomplete emptying of the bladder) and irritative symptoms (nocturia, daytime frequency, urgency, burning) of BPH were evaluated at each visit by patient-assessed symptom questionnaires. (nih.gov)
  • Statistically significant improvements of 2.3 to 3.3 mL/sec in maximum flow rate were seen with doxazosin mesylate in STUDIES 1 and 2 , compared to 0.1 to 0.7 mL/sec with placebo. (nih.gov)
  • Seventy-two percent, 80%, and 85% of the patients on 25 mg, 50 mg, and 100 mg of VIAGRA, respectively, achieved erections hard enough for sex, compared to 50% on placebo. (viagra.com)
  • This treatment was administered at three week intervals to 17 patients. (prinsesmaximacentrum.nl)
  • Alexander Kiani Introduction: Treatment-free remission (TFR) is increasingly considered as treatment goal for patients with chronic myeloid leukemia (CML), but information. (karger.com)
  • is indicated for the treatment of erectile dysfunction paroxetine mesylate noven. (terminally-incoherent.com)
  • However, patient resistance and cytotoxicity make secondary lines of treatment, such as omacetaxine mepesuccinate, a necessity. (altmetric.com)
  • For the treatment of transfusional iron overload in patients with chronic anemia. (nih.gov)
  • Thus, ChoK constitutes a novel bona fide molecular target for the treatment of breast cancer patients. (aacrjournals.org)
  • As the new virus continues to spread and claim lives around the globe, doctors and patients are eager for treatment options. (novartis.com)
  • Patients in all treatment groups are receiving standard of care for COVID-19. (novartis.com)
  • For treatment-naïve patients, take atazanavir simultaneously with the H2RA or at least 10 h afterwards. (medscape.com)
  • See dosage adjustment recommendations if coadministered in treatment-experienced patients. (medscape.com)
  • The commonest treatment for thalas- sion in thalassaemia patients with some saemia patients, apart from bone marrow degree of systolic function impairment. (who.int)
  • Efforts have been made to establish a the patients to determine pulse rate interval, safe treatment of cardiac complications in QRS duration, arrhythmia and systolic and thalassaemia patients. (who.int)
  • Over the past 60 years, due to the advancement of hemo- the Work Group and tasked it with planning, developing, dialysis (HD) technology and the introduction of medical reviewing, and disseminating appropriate HD treatment insurance, dialysis treatment has become widespread, en- guidelines in accordance with international standards. (bvsalud.org)
  • Early diagnosis and effective treatment of TB among HIV-infected patients are critical for curing TB, minimizing the negative effects of TB on the course of HIV, and interrupting the transmission of Mycobacterium tuberculosis to other persons in the community. (cdc.gov)
  • Physicians and patients also should be aware that paradoxical reactions might occur during the course of TB treatment when antiretroviral therapy restores immune function. (cdc.gov)
  • Adult patients with myelodysplastic/myeloproliferative diseases (MDS/MPD) associated with PDGFR (platelet-derived growth factor receptor) gene re-arrangements as determined with an FDA-approved test. (hikma.com)
  • Adult patients with aggressive systemic mastocytosis (ASM) without the D816V c-Kit mutation as determined with an FDA-approved test or with c-Kit mutational status unknown. (hikma.com)
  • Adult patients with hypereosinophilic syndrome (HES) and/or chronic eosinophilic leukemia (CEL) who have FIP1L1-PDGFRα fusion kinase (mutational analysis or FISH demonstration of CHIC2 allele deletion) and for patients with HES and/or CEL who are FIP1L1-PDGFRα fusion kinase negative or unknown. (hikma.com)
  • Considering that only few patients with gastrointestinal stromal tumors have been reported in the obstetrical and gynecological literature, the awareness of such an entity by the obstetricians-gynecologists is necessary in order to facilitate coordinated approach with the general surgeons and oncologists for the optimal care of the patients. (scirp.org)
  • In a separate study, an average of 86-fold increase in the zidovudine susceptibility of patient isolates (n = 24) was observed after 24 weeks of combination therapy with RESCRIPTOR and zidovudine. (drugs.com)
  • One study demonstrated that 67 percent of patients treated initially with both 50 mg of Januvia and 1,000 mg of metformin twice daily achieved HbA1c levels below 7, compared to 44 percent of those receiving only metformin. (bioworld.com)
  • Boehringer Ingelheim announced results from the RE-COVER II study evaluating dabigatran compared to warfarin in patients diagnosed with acute deep vein thrombosis (DVT) and/or pulmonary embolism (PE). (empr.com)
  • In addition to hydroxychloroquine, Novartis plans to sponsor or co-sponsor clinical trials to study ruxolitinib and canakinumab for hospitalized patients with COVID-19 infections. (novartis.com)
  • A Scandinavian Sarcoma Group study of 97 patients. (bvsalud.org)
  • The study included 15 thalassaemia allow the formation of more excretable patients aged 15-25 years who had some iron complexes [1,3]. (who.int)
  • Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial. (cdc.gov)
  • We recognize the importance of answering the scientific question of whether hydroxychloroquine will be beneficial for patients with COVID-19 disease," said John Tsai, Head of Global Drug Development and Chief Medical Officer at Novartis. (novartis.com)
  • Data from a 743-patient trial presented at ADA showed that adding the drug to metformin resulted in significant decreases in HbA1c. (bioworld.com)
  • This patient information sheet applies only to approved uses of the drug. (cancer.gov)
  • Weigh patients regularly and manage unexpected rapid weight gain by drug interruption and diuretics. (hikma.com)
  • The drug infusion was discontinued in patients devel- oping all these adverse effects. (who.int)
  • Gilman and co-workers were the first to introduce chemotherapy into clinical practice at the end of the Second World War when they used nitrogen mustard to treat a patient with advanced malignant lymphoma. (nature.com)
  • The delivery of quality pharmacy services is thought to be important by virtue of its influence on patient's satisfaction and hence better patient compliance/adherence. (uwi.edu)
  • Patients with oral malignant melanoma often recall having an existing oral pigmentation months to years before diagnosis, and the condition may even have elicited prior comment from examining physicians and dentists (or healthcare providers, when considering the auxiliaries). (medscape.com)
  • Patients receiving oral contraceptives should be instructed that alternate or additional contraceptive measures should be used during therapy with VIRACEPT. (pharmacycode.com)
  • Thus into 3 different forms: acute pericarditis, appropriate regimens for managing cardiac congestive heart failure and arrhythmia due conditions in thalassaemia major patients to haemosiderosis, and chronic anaemia still need further investigation. (who.int)
  • Find Clinical Trials for Sunitinib Malate - Check for trials from NCI's list of cancer clinical trials now accepting patients. (cancer.gov)
  • These will make the patient awake, restless, or experience limb discomfort, among other things, causing significant disruption to the procedure and perhaps jeopardising its flawless conclusion [ 3 ]. (hindawi.com)
  • Conclusion: In the patients with a pelvic mass, especially if unusual symptoms and laboratory data being not compatible with gynecological disease, the possibility of diseases other than a gynecologic disease has to be considered. (scirp.org)
  • Screening of patients with iron overload to identify hemochromatosis and porphyria cutanea tarda. (medscape.com)
  • Valenti L, Varenna M, Fracanzani AL, Rossi V, Fargion S, Sinigaglia L. Association between iron overload and osteoporosis in patients with hereditary hemochromatosis. (medscape.com)
  • The chemical name of doxazosin mesylate is 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl) piperazine methanesulfonate. (nih.gov)
  • In patients treated with RESCRIPTOR, the mutations in RT occurred predominantly at amino acid positions 103 and less frequently at positions 181 and 236. (drugs.com)
  • It is used to reduce the risk of stroke and systemic EMBOLISM in patients with nonvalvular atrial fibrillation. (bvsalud.org)
  • Adding to CDC's current recommendations for administering isoniazid preventive therapy to HIV-infected persons with positive tuberculin skin tests and to HIV-infected persons who were exposed to patients with infectious TB, this report also describes in detail the use of new short-course (i.e., 2 months) multidrug regimens (e.g., a rifamycin, such as rifampin or rifabutin, combined with pyrazinamide) to prevent TB in persons with HIV infection. (cdc.gov)
  • The consultants then used this review as the basis for updating the recommendations for HIV-infected patients with TB (Part II). (cdc.gov)
  • Genotypic analysis of HIV-1 isolates from patients receiving RESCRIPTOR plus zidovudine combination therapy (n = 79) showed resistance-conferring mutations in all isolates by Week 24 of therapy. (drugs.com)
  • Bristol-Myers Squibb (BMS) is a specialty biopharmaceutical company that is engaged in discovery, development, licensing and manufacturing, marketing, distribution and sale of medicines and related medical products to patients with serious diseases. (pharmaceutical-technology.com)
  • At Teva, we strive to deliver quality medicines to patients around the world with integrity and ethical business practices. (tevapharm.com)
  • As part of its research and development commitment, Novartis has formed a clinical investigation team to provide rapid access for approved clinical requests and support of clinical evaluation of its medicines to be repurposed and address the needs of patients with COVID-19 infections. (novartis.com)
  • Technical Description of Tape Data Set Name: NAMC1990 Number of Reels: 1 Number of Recording Tracks: 9 Density (bpi): 1600 or 6250 Language EBEDIC Parity ODD Record Length: 153 Blocksize: 15,300 Number of Records 43,469 Computer Compatibility IBM 360 OR 370 METHODOLOGY Scope of the Survey The basic sampling unit for the NAMCS is the physician-patient encounter or visit. (cdc.gov)
  • a factor highly expressed in orbital tissue from patients with GO. (eur.nl)